Fundraising FoxVirtuoso Therapeutics, Inc.
1 known investors
Find your way into Virtuoso Therapeutics, Inc.
Sign up to see every warm intro you have to Virtuoso Therapeutics, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Virtuoso Therapeutics, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Virtuoso Therapeutics is an oncology-focused biotech developing novel bispecific antibody therapies aimed at addressing challenges like efficacy and therapeutic window. It operates a hybrid US-China model for virtual R&D, drawing on science and talent from both regions.
Founders & leadership
Investors · 1
Related companies · 4
Ventus TherapeuticsVentus discovers and develops small-molecule medicines using its proprietary ReSOLVE platform, focused on structure-based drug discovery. The company has advanced lead programs in Parkinson's disease and lupus through Phase 2 clinical trials.
Vivace TherapeuticsVivace Therapeutics is an oncology-focused drug discovery and development company creating small-molecule inhibitors targeting the Hippo-YAP pathway to treat cancers including mesothelioma, meningioma, and various other tumor types. The company adopts a capital-efficient approach to advance novel cancer therapeutics, with potential applications also in fibrotic disease.
Verve TherapeuticsCambridge, MA biotech developing single-course in vivo base editing medicines to permanently lower cardiovascular disease risk.
TherivabioTheriva Biologics is a clinical-stage company developing therapeutics for cancer and related diseases, including an oncolytic adenovirus platform (VCN-01) and enzyme-based candidates for gastrointestinal and systemic conditions (SYN-004, SYN-020). It is a publicly traded biopharmaceutical company (NYSE American: TOVX) focused on areas of high unmet medical need.
Companies working in the same space as Virtuoso Therapeutics, Inc..
Frequently asked questions
- What does Virtuoso Therapeutics, Inc. do?
- Virtuoso Therapeutics is an oncology-focused biotech developing novel bispecific antibody therapies aimed at addressing challenges like efficacy and therapeutic window. It operates a hybrid US-China model for virtual R&D, drawing on science and talent from both regions.
- Who founded Virtuoso Therapeutics, Inc.?
- Virtuoso Therapeutics, Inc. was founded by Sofie Qiao.
- Who are Virtuoso Therapeutics, Inc.'s investors?
- Virtuoso Therapeutics, Inc.'s investors include Canaan Partners.